$42.0M
The equity round was led by EQT Life Sciences and Sectoral to support international expansion and clinical trials.
P
Phagenesis
Phagenesis develops neurostimulation technology to treat swallowing disorders.
Manchester, UK—Founded 2007
$42.0MTotal raised
Manchester-based medical device startup that develops neurostimulation systems to treat swallowing disorders.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Phagenesis's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
MW
Mark Wyatt
CM
Conor Mulrooney
Co-Founder
SH
Shaheen Hamdy
Co-Founder
Reinhard Krickl
CEO
Reinhard brings extensive medical technology leadership and board experience, currently serving as chief executive officer at ImageBiopsy Lab and Phagenesis alongside venture partner roles.
LinkedIn